Similarly, we observed that silencing TGFBI in SKOV-3 and Caov-3 cells resulted in increased expression of CDH1 (E-cadherin) and decreased CDH2 (N-cadherin) (Fig. 4), suggesting that TGFBI affected the metastatic capabilities of ovarian cancer cells via EMT reprogram. Here, TGFBI is linked to ovarian carcinoma.